US20100256390A1 - Processes for the preparation of pyrazoles - Google Patents

Processes for the preparation of pyrazoles Download PDF

Info

Publication number
US20100256390A1
US20100256390A1 US12/665,738 US66573808A US2010256390A1 US 20100256390 A1 US20100256390 A1 US 20100256390A1 US 66573808 A US66573808 A US 66573808A US 2010256390 A1 US2010256390 A1 US 2010256390A1
Authority
US
United States
Prior art keywords
formula
compound
hal
reaction
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/665,738
Inventor
Martin Charles Bowden
Brian David Gott
David Anthony Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Syngenta Crop Protection LLC
Original Assignee
Syngenta Ltd
Syngenta Crop Protection LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38812166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20100256390(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syngenta Ltd, Syngenta Crop Protection LLC filed Critical Syngenta Ltd
Publication of US20100256390A1 publication Critical patent/US20100256390A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/74Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/76Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Definitions

  • the present invention relates to novel processes for the production of 3-halomethyl-1-methyl-1H-pyrazoles, which are useful as intermediates in the production of fungicides.
  • 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid and 3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid are valuable intermediates in the preparation of pyrazolyl carboxanilide fungicides, as described, for example, in WO 03/070705 and WO 03/074491.
  • the aim of the present invention is therefore to provide novel processes for the production of key intermediates in the synthesis of 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid and 3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid that makes it possible to prepare said acids with high regioselectivity (in respect to the two nitrogen atoms of the pyrazole ring), in high yields and good quality in an economically advantageous and easily handled way.
  • the invention relates to a process for the preparation of a compound of formula (I)
  • Hal and Hal′ are independently Cl or F, and R 1 is H, Cl or F, comprising the steps of
  • R 2 is C1-6 alkyl
  • Hal, Hal′ and R 1 are as defined above, and
  • the invention provides a process for the preparation of a compound of formula (VI)
  • Hal, Hal′ and R 1 are as defined above and R 3 is selected from H and C1-6 alkyl comprising reacting a hydrazide of formula (XXIII)
  • Hal, Hal′ and R 1 are as defined above,
  • R3 is as defined above.
  • the invention provides a process for the preparation of a compound of formula (VI)
  • Hal, Hal′ and R 1 are as defined above and R 3 is selected from H and C1-6 alkyl comprising reacting a compound of formula (XXV)
  • Hal, Hal′, R 1 and R 3 are as defined above with chloramine.
  • the invention relates to a compound of formula X
  • the invention relates to a compound of formula VIII
  • the invention relates to a compound of formula VII
  • step i) of the reaction according to a first embodiment of the invention a compound of formula (II) reacts with an enol ether of formula (III) to give a 4-alkoxy-3-en-2-one of formula (IV) (Scheme 1)
  • leaving group refers to a moiety that can be displaced by enol ether (III) to form a carbon-carbon bond present in compound (IV).
  • Preferred leaving groups are halogens. A more preferred leaving group is chlorine.
  • R 2 is ethyl
  • reaction of compound (II) with the enol ether (III) may take place in a suitable solvent. Alternatively, and preferably, the reaction takes place in the absence of a solvent.
  • Preferred solvents are toluene, hexane, dichloromethane and diethylether.
  • the reaction is conducted under an inert atmosphere. More preferably, the reaction is conducted under a nitrogen atmosphere. Preferably, the reaction proceeds with purge to help remove volatile co-products.
  • the reaction takes place in the presence of a base.
  • bases are pyridine, alkyl pyridines or trialkylamines.
  • the reaction occurs in the absence of base.
  • the enol ether (III) is present in excess relative to the compound (II). More preferably, the enol ether is present in an amount of between 1.1 and 10 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of between 1.2 and 5 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of between 1.5 and 2.5 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of about 2 equivalents relative to the amount of compound (II) on a molar basis.
  • the enol ether (III) is added to the compound (II). More preferably, the enol ether (III) is added to the compound (II) over at least 1 hour. More preferably, the enol ether (III) is added to the compound (II) over at least 4 hours. More preferably, the enol ether (III) is added to the compound (II) over about 8 hours.
  • the reaction is cooled during the addition of the enol ether (III) to the compound (II).
  • the reaction is cooled to between ⁇ 20 and ⁇ 40° C. during the addition of the enol ether (III) to the compound (II).
  • the reaction is allowed to continue for at least 1 hour. More preferably, the reaction is allowed to continue for at least 6 hours. More preferably, the reaction is allowed to continue for at least 8 hours.
  • reaction mixture may be necessary or desirable to isolate the 4-alkoxy-3-en-2-one of formula (IV), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2 nd Edition ), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • step ii) of the reaction according to a first embodiment of the invention a 4-alkoxy-3-en-2-one of formula (IV) reacts with methyl hydrazine to give a 3-halomethyl-1-methyl-1H-pyrazole (I) (Scheme 2).
  • reaction of compound (IV) with methyl hydrazine preferably takes place in a suitable solvent. Alternatively the reaction takes place in the absence of a solvent.
  • Preferred solvents are xylene, toluene, mesitylene, tert-butyl benzene, chlorobenzene, 1,2-dichlorobenzene, tetrahydrofuran, diethyl ether and hexane.
  • a more preferred solvent is tetrahydrofuran.
  • methyl hydrazine is used in an amount of 0.7 to 1.3 equivalents relative to the amount of 4-alkoxy-3-en-2-one of formula (IV).
  • the methyl hydrazine is added to the 4-alkoxy-3-en-2-one of formula (IV).
  • both the methyl hydrazine and the 4-alkoxy-3-en-2-one of formula (IV) are both dissolved in solvent. Addition preferably takes place over a period of between 5 minutes and 10 hours, more preferably over about 5 hours.
  • the reaction is preferably held at between 0 to 50° C., more preferably at between 35 to 45° C.
  • reaction mixture may be necessary or desirable to isolate the pyrazole (I), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2 nd Edition ), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • Suitable techniques include recrystallization, distillation, and chromatography.
  • pyrazole (I) is subjected to a halogenation step to convert it to 4-halopyrazole of formula (V) (Scheme 3)
  • the halogenation reaction is conducted in a solvent.
  • a preferred solvent is carbon tetrachloride.
  • the reaction is conducted under an inert atmosphere. More preferably, the reaction is conducted under a nitrogen atmosphere. Preferably, the reaction proceeds with purge to help remove volatile co-products.
  • X is Br.
  • a preferred halogenating agents are elemental bromine (Br 2 ), N-bromosuccinimide and 1,3-dibromo-5,5-dimethylhydantoin. More preferably, the halogenating agent is Br 2 in the presence of an iron compound, preferably iron powder.
  • the halogentating agent is used in excess relative to pyrazole (I). More preferably, the halogentating agent is used in amount of 1.5 to 5 equivalents relative to pyrazole (I) on a molar basis.
  • the reaction is allowed to continue for at least 1 hour. More preferably, the reaction is allowed to continue for from 1 to 48 hours. More preferably, the reaction is allowed to continue for from 1 to 5 hours.
  • 4-halopyrazole (V) is subjected to a carbonylation step to convert it to 4-carboxypyrazole of formula (VI) (Scheme 4)
  • R 3 is H or C1-6 alkyl.
  • R 3 is Ethyl or H.
  • Reagent R 3 OH is preferably present in excess relative to 4-halopyrazole (V), preferably in an amount of from 100 to 150 equivalents relative to the amount of (V) on a molar basis.
  • Carbon monoxide is preferably used in excess relative to the amount of (V).
  • the reaction takes place in the presence of a palladium catalyst.
  • the palladium catalyst is preferably a palladium (II) or palladium (0) catalyst.
  • Preferred catalysts are tris(triphenylphosphine) palladium (II) chloride, bis(triphenylphosphine) palladium (II) chloride, and tetrakis(triphenylphosphine)palladium(0).
  • a preferred catalyst is tris(triphenylphosphine) palladium (II) chloride.
  • the palladium catalyst is used in an amount of between 0.01 and 0.5 equivalents relative to the amount of 4-halopyrazole (V), more preferably between 0.1 and 0.3 equivalents.
  • triphenylphosphine is added to the reaction, preferably in an amount of 0.5 to 0.7 equivalents.
  • the reaction is conducted at a temperature of from 50 to 200° C., more preferably at a temperature of from 100 to 150° C.
  • bases are nitrogen-containing organic bases, preferably tertiary amines, more preferably trialkylamines, preferably trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine.
  • Alternative preferred bases are N,N-dimethylaniline or N-methylmorpholine, piperidine, pyrrolidine, alkali metal or alkaline earth metal alcoholates, preferably lithium, sodium or potassium alcoholates, preferably methanolates, ethanolates or butanolates, or inorganic bases, preferably hydroxides, more preferably NaOH or KOH, or hydrides, preferably NaH.
  • tertiary amines preferably trialkylamines, more preferably trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine.
  • Triethylamine is very highly preferred.
  • Suitable amounts of base for that reaction are, for example, from 1 to 10 equivalents, especially from 4 to 6 equivalents.
  • the reaction time is generally from 1 to 48 hours, preferably from 1 to 36 hours, more preferably 1 to 18 hours.
  • the reaction according to the invention is carried out typically at elevated pressure, preferably 1 to 20 bar, more preferably 10 to 15 bar.
  • an optional further step comprises hydrolyzing the group R 3 to a compound (VI) wherein R 3 is hydrogen, or a salt form thereof (Scheme 5).
  • R 3 is C1-6 alkyl
  • Hydrolysis can be effected under either acid or basic conditions. If basic conditions are employed, generally a salt form of 4-carboxypyrazole (VI) is obtained. A further step of acidification to convert the salt to the free acid may be employed.
  • Preferred bases for the hydrolysis reaction are metal hydroxides and metal carbonates. More preferred bases are alkali metal hydroxides. Still more preferred are sodium, potassium and lithium hydroxide. Most preferred is sodium hydroxide.
  • the base is used in excess relative to 4-carboxypyrazole (VI). More preferably, between 1 and 5 equivalents of base are used. Still more preferably, between 1 and 3 equivalents of base are used.
  • water is present in excess.
  • a co-solvent is present.
  • a preferred co-solvent is ethanol.
  • the hydrolysis preferably takes place at between 0 and 200° C., more preferably at between 50 and 150° C.
  • the free acid (VI) may be liberated by treatment with acid.
  • Preferred acids are mineral acids, preferably hydrochloric or sulphuric acid. Most preferred is hydrochloric acid.
  • mineral acids or organic acids may be used. Preferred are mineral acids. More preferred are hydrochloric and sulphuric acid. Most preferred is hydrochloric acid.
  • At least 0.01 equivalents of acid relative to the amount of (VI) on a molar basis are employed, more preferably between 0.01 and 5 equivalents, still more preferably 1 to 5 equivalents.
  • acid hydrolysis occurs at a temperature of between 40 and 100° C.
  • the reaction sequence includes a halogen exchange step.
  • halogen exchange refers to a reaction wherein halogen atoms of one element are exchanged for halogen atoms of a second, different element.
  • chlorine atoms are exchanged for fluorine atoms.
  • Halogen exchange may be conducted at any suitable step of the reaction sequence.
  • halogen exchange is effected on 3-dichloromethyl-1-methyl-1H-pyrazole (VII) to give 3-difluoromethyl-1-methyl-1H-pyrazole-4-carbaldehyde (VIII) (Scheme 6).
  • halogen exchange is effected on 4-bromo-3-dichloromethyl-1-methyl-1H-pyrazole (IX) to give 4-bromo-3-fluoromethyl-1-methyl-1H -pyrazole (X) (Scheme 7).
  • halogen exchange is effected on 3-dichloromethyl-1-methyl-1H-pyrazole-4-carboxylate (XI) or a salt form thereof to give 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylate (XII) (Scheme 8).
  • Halogen exchange may be conducted under a variety of conditions. Preferably, halogen exchange is conducted in the presence of a source of F ⁇ ions.
  • Preferred reagents are AgF, KF, HgF 2 , Bu 4 N + HF 2 ⁇ , BrF 3 , Et 3 N.2HF, Et 3 N.3HF and HF plus SbF 3 .
  • a very highly preferred reagent is Et 3 N.3HF.
  • the halogen exchange reaction is optionally conducted in a solvent. Alternatively, and preferably, the reaction is conducted under solvent-free conditions.
  • the reaction is held at between 0 and 250° C. More preferably, the reaction is held at between 50 and 200° C. More preferably, the reaction is held at between 125 and 175° C. Most preferably, the reaction is held at about 150° C.
  • Suitable techniques include recrystallization, distillation, and chromatography.
  • the reaction takes place in a solvent.
  • Dimethylformamide is preferred.
  • the reaction occurs under acid catalysis.
  • p-Toluene sulphonic acid is preferred.
  • 4-carboxypyrazole (VI) may be hydrolysed to the free acid or a salt form thereof as outlined above.
  • the enamine (XXV) is reacted with a base prior to reaction with chloramine.
  • a preferred base is sodium hydride.
  • the reaction takes place in a solvent.
  • solvents are diethyl ether, tetrahydrofuran and mixtures thereof.
  • 4-carboxypyrazole (VI) may be hydrolysed to the free acid or a salt form thereof as outlined above.
  • Hal, Hal′ and R 1 are all fluorine.
  • Hal and Hal′ are fluorine and R 1 is hydrogen.
  • Hal and Hal′ are both chlorine, and R 1 is hydrogen.
  • the present invention relates to a process for the production of a compound of formula XIII
  • R 1 is C 1 -C 6 alkyl, to form a compound of formula XV
  • R 1 is as defined above;
  • R 2 is C 1 -C 6 alkyl
  • single compounds of formula (III), such as compounds of formula (III), wherein R 1 is ethyl, can be used or mixtures thereof.
  • An example of such a mixture are compounds of formula (III), wherein in R 1 is methyl, mixed with compounds of formula (III), wherein R 1 is ethyl.
  • R 1 is ethyl.
  • the reaction according to the invention is preferably carried out in a temperature range of from ⁇ 40° C. to 0° C., especially from ⁇ 40° C. to ⁇ 20° C.
  • the reaction can be carried out in the presence or absence of a base.
  • bases include pyridine, alkyl pyridines or trialkylamines.
  • the reaction can be carried out without solvent or in an inert solvent.
  • Preferred inert solvents are, for example, toluene, hexane, dichloromethane or diethylether.
  • the reaction is carried out without a solvent.
  • the compound of formula (III) for example ethylenol ether
  • the compound of formula (III) can be used in equimolar amounts, in sub-equimolar amounts or in excess relative to compounds of formula XIV, preferably the compound of formula (III) is used in excess, more preferably in an 1.5-fold to 3-fold excess.
  • the reaction according to the invention may be carried out in a dry inert gas atmosphere.
  • nitrogen can be used as inert gas.
  • the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours.
  • the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
  • the reaction according to the invention is preferably carried out in a temperature range of from 0° C. to 50° C., especially from 10° C. to 25° C.
  • the reaction is conveniently carried out in an inert solvent.
  • inert solvents are, for example, xylene, toluene, mesitylene, tert-butyl benzene, chlorobenzene, 1,2-dichlorobenzene, tetrahydrofuran, diethyl ether and hexane, preferably tetrahydrofuran.
  • methylhydrazine in the reaction according to the invention, can be used in equimolar amounts, in sub-equimolar amounts or in excess relative to compounds of formula XV, preferably methylhydrazine is used in equimolar amounts.
  • the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
  • the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
  • the fluorination according to the invention is preferably carried out in a temperature range of from 100° C. to 200° C., especially from 140° C. to 160° C.
  • the preferred fluorinating agent is tris(hydrogen fluoride)-triethylamine.
  • the fluorinating agent is typically used in excess relative to compounds of formula VII, preferably in a 2-fold to 5-fold excess.
  • the fluorination can be carried out without solvent or in an inert solvent.
  • Preferred inert solvents are, for example, acetonitrile, chloroform, carbon tetrachloride and dichloromethane. Use of excess tris(hydrogen fluoride)-triethylamine, which then acts as solvent is preferred.
  • the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
  • the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at elevated pressure.
  • the bromination according to the invention is preferably carried out in a temperature range of from 0° C. to 100° C., preferably from 20° C. to 40° C.
  • reaction is conveniently carried out in an inert solvent.
  • a preferred inert solvent is, for example, carbon tetrachloride.
  • Preferred brominating agents are, for example, bromine in the presence of an iron catalyst, N-bromosuccinimide and 1,3-dibromo-5,5-dimethylhydantoin; preferably bromine in the presence of an iron catalyst.
  • brominating agent is bromine in the presence of an iron catalyst
  • said bromine is typically used in excess relative to compounds of formula VIII, preferably in a 1.5-fold to 5-fold excess; and said iron catalyst is used typically in the form of iron powder and in the range of from 0.1 to 1 equivalents relative to compounds of formula VIII, especially from 0.3 to 0.8 equivalents.
  • the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
  • the reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
  • the preferred C 1 -C 6 alkanol is ethanol; but also mixtures C 1 -C 6 alkanols can be used, such as a mixture of methanol/ethanol.
  • the reaction according to the invention is preferably carried out in a temperature range of from 50° C. to 200° C., especially from 100° C. to 150° C.
  • the reaction is conveniently carried out in a large excess of the C 1 -C 6 alkanol, such as a 100-fold to 150-fold excess, which then acts as solvent.
  • a large excess of the C 1 -C 6 alkanol such as a 100-fold to 150-fold excess, which then acts as solvent.
  • ethanol is used.
  • a large excess of carbon monoxide is used.
  • a suitable palladium catalyst is tris(triphenylphosphonium)palladium(II)chloride.
  • Said palladium catalyst is used generally in the range of from 0.1 to 0.5 equivalents relative to compounds of formula X, especially from 0.1 to 0.3 equivalents. If tris(triphenylphosphonium)palladium(II)chloride is used as palladium catalyst, then generally triphenyl phosphine is also added to the reaction mixture in amounts of from 0.5 to 0.7 equivalents relative to compounds of formula X.
  • Suitable bases are, for example, nitrogen-containing organic bases, such as, for example, tertiary amines, such as trialkylamines, e.g. trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine, N,N-dimethylaniline or N-methylmorpholine, piperidine, pyrrolidine, alkali metal or alkaline earth metal alcoholates, such as, for example, lithium, sodium or potassium alcoholates, especially methanolates, ethanolates or butanolates, or inorganic bases, such as hydroxides, e.g.
  • Bases to which preference is given are tertiary amines, such as trialkylamines, e.g. trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine, especially triethylamine.
  • Suitable amounts of base for that reaction are, for example, from 1 to 10 equivalents, especially from 4 to 6 equivalents.
  • the reaction time is generally from 1 to 48 hours, preferably from 1 to 36 hours, more preferably 1 to 18 hours.
  • the reaction according to the invention is carried out typically at elevated pressure, such as 1 to 20 bar, preferably 10 to 15 bar.
  • Process step b6) the saponification of compounds of formula (XII) to form the compound of formula (XIII), can be carried out as described under step b6.1) (alkaline saponification) or under step b6.2) (acidic saponification).
  • Step b6.1) can be divided into two sub-steps: i) the formation of the anion of the compound of formula (XIII) (“the anion”) by adding a base and ii) the formation of the compound of formula (I) (“the free acid”) by later adding an acid.
  • hydroxide base is used to form the anion, then NaOH or KOH, especially NaOH, is preferred.
  • a suitable amount of hydroxide base is, for example, at least one equivalent relative to compounds of formula (XII), preferably from 1 to 5 equivalents; more preferably from 1 to 3 equivalents.
  • inorganic bases such as hydroxides, for example LiOH, NaOH or KOH, or carbonates, for example sodium carbonate, are preferred.
  • hydroxides for example LiOH, NaOH or KOH
  • carbonates for example sodium carbonate
  • at least one equivalent of water and at least one equivalent of the base relative to compounds of formula (XII) are used.
  • the formation of the anion can be carried out in an inert solvent, such as ethanol.
  • the formation of the anion is preferably carried out in a temperature range of from 0° C. to 200° C.
  • the reaction time for anion formation is generally from 1 to 48 hours, preferably from 1 to 18 hours.
  • Said anion formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
  • Suitable acids are inorganic acids, such as hydrochloric acid or sulfuric acid; or organic acids, such as formic acid, acetic acid or propionic acid. Preference is given to inorganic acids and special preference is given to hydrochloric acid.
  • the acid is added in a temperature range of from 50° C. to 95° C.
  • the reaction time for formation of the free acid is generally from 1 to 48 hours, preferably from 1 to 18 hours.
  • Said free acid formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
  • the acid used in step b6.2) is typically an inorganic acid, such as hydrochloric acid or sulfuric acid; or an organic acid, such as formic acid, acetic acid or propionic acid.
  • aqueous solutions of the acid are used in step b6.2).
  • a preferable amount of water is at least one equivalent relative to compounds of formula (XII).
  • a preferable amount of acid is at least 0.01 equivalents relative to compounds of formula (XII), more preferably from 0.01 to 5 equivalents; even more preferably from 1 to 5 equivalents.
  • the formation of the free acid is preferably carried out in a temperature range of from 40° C. to 100° C.
  • the reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours.
  • Said free acid formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
  • the second embodiment of the present invention makes it possible to produce compounds of formula I in a high yield, with a high degree of regioselectivity and at low cost.
  • the compounds of formula (X), (VII) and (VIII) are valuable intermediates for the preparation of compounds of formula (XIII) and were developed specifically for the present process according to the invention.
  • the present invention accordingly relates also to those compounds.
  • steps b1), b2), b3), b4) and b5) are performed as described above.
  • R 1 and R 2 stands for C 1 -C 6 alkyl and TREAT HF means tris(hydrogen fluoride)-triethylamine.
  • the invention includes, in separate embodiments, the following multi-step processes, which involve:
  • Dichloroacetyl chloride (114.9 g, compound of formula XIV) was charged to a clean/oven dried 250 ml 3-necked flask fitted with nitrogen feed, syringe feed, thermometer and a PTFE coated magnetic stirrer.
  • the reactor was vented via a cold finger condenser and water condenser to follow.
  • a caustic scrubber system was connected to the vent from the water condenser system.
  • the agitation was provided by a magnetic stirrer/hotplate fitted with a drykold acetone bath.
  • the cold finger condenser was filled with the same cooling mixture.
  • the reactor contents were agitated and the contents cooled to ⁇ 40° C. with a gentle nitrogen purge applied to the reactor.
  • 1,1-Dichloro-4-ethoxy-but-3-en-2-one (0.99 g, compound of formula XVI) was dissolved in tetrahydrofuran (12.5 ml) in a clean/dry 50 ml 3-necked flask fitted with thermometer, condenser and syringe feed system. The top of the condenser was back pressured with a gentle flow of nitrogen. The reactor contents were agitated and heated to 40° C. then the N-methyl hydrazine (0.26 g) was dissolved in tetrahydrofuran (25 ml) and the resultant solution syringe pump fed into the reactor over a 5 hour period. The reaction mixture was agitated overnight under nitrogen to complete.
  • Formaldehyde (7.4 g) was charged to the reactor and the mixture agitated for 30 minutes at room temperature accompanied by a small exotherm reaction. 1 g Pt/C was added and washed in with methanol (20 ml). The Parr reactor was sealed, purged with nitrogen three times, purged with hydrogen three times (all to 200 psi) and then pressurized up to 200 psi with hydrogen. Agitation and external heating were applied to heat the reaction to 50° C. The reactor was held under these conditions for 3 h and then allowed to cool. The system was purged three times with nitrogen to 200 psi. The contents were removed and filtered. The solvent was removed under vacuum, filtered and concentrated under vacuo. The compound of formula XX was obtained in the form of an orange oil (9.1 g). Yield 40% total isomers and 36% of the desired isomer. The product was analysed by GC, GCMS and NMR ( 1 H and 19 F).
  • a 25 ml reaction tube was fitted with a magnetic stirrer, thermometer, condenser and nitrogen atmosphere.
  • Dimethylformamide (10 g), ethyl propargylate (0.14 g), the compound of formula XX (0.24 g) and p-toluene sulphonic acid (0.028 g) were charged to the reaction tube.
  • the mixture was stirred at 50° C. overnight, 80° C. overnight and then 110° C. overnight to give the desired product (compound of formula XVII).
  • the compound of formula (I) can be formed from the compound of formula (V) via step b6) as described above.
  • the compound of formula (XVII) can be formed from the compound of formula (XX) via the methology described in comparative example C5 above.
  • the compound of formula (XII) can be formed from the compound of formula (XVII) via step b6) as described above.
  • a 100 ml conical flask was fitted with a magnetic stirrer and thermometer. Diethyl ether (31 ml) and ammonium chloride (0.91 g) were charged to the flask. The mixture was cooled to ⁇ 10° C. and aqueous ammonia solution (1.7 g) was added. Sodium hypochlorite (14.3 g) solution was charged over 10 minutes to the vigorously stirred solution at ⁇ 10° C., and the reaction was then stirred at ⁇ 10° C. for 0.5 hr. The organic layer was separated, washed with brine, dried over CaCl 2 for 1 hr at ⁇ 15° C. The desired chloramine was generated as a 3% chloramine solution in diethylether.
  • This tetrahydrofuran solution was added slowly to the chloramine/diethylether-solution described above (6.22 mmol, 5.0 eq) at ⁇ 15° C. The reaction was stirred at ⁇ 15° C. for 1 h and then allowed to warm to ambient temperature. A new solution of chloramine in diethylether (2.7% strength) was prepared as described above. Additional sodium hydride dispersion (0.20 g, 4.96mmol, 4.0 eq) and chloramine (new solution) (10.4 g, 5.46 mmol, 4.4 eq) were added and the reaction was stirred for 1 h at ambient temperature.
  • the compound of formula (XIII) can be formed from the compound of formula (XVII) via step b6) as described above.

Abstract

The present invention relates to novel processes for the production of compounds of formula (I) wherein Hal and Hal′ are independently Cl or F, and R1 is H, Cl or F.
Figure US20100256390A1-20101007-C00001

Description

  • The present invention relates to novel processes for the production of 3-halomethyl-1-methyl-1H-pyrazoles, which are useful as intermediates in the production of fungicides.
  • 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid and 3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid are valuable intermediates in the preparation of pyrazolyl carboxanilide fungicides, as described, for example, in WO 03/070705 and WO 03/074491.
  • The aim of the present invention is therefore to provide novel processes for the production of key intermediates in the synthesis of 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid and 3-trifluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid that makes it possible to prepare said acids with high regioselectivity (in respect to the two nitrogen atoms of the pyrazole ring), in high yields and good quality in an economically advantageous and easily handled way.
  • SUMMARY OF THE INVENTION
  • According to a first aspect, the invention relates to a process for the preparation of a compound of formula (I)
  • Figure US20100256390A1-20101007-C00002
  • wherein Hal and Hal′ are independently Cl or F, and R1 is H, Cl or F, comprising the steps of
  • i) reacting a compound of formula (II)
  • Figure US20100256390A1-20101007-C00003
  • wherein Hal, Hal′ and R1 are as defined above, and LG is a leaving group, with an enol ether of formula (III)
  • Figure US20100256390A1-20101007-C00004
  • wherein R2 is C1-6 alkyl,
  • to give a compound of formula (IV)
  • Figure US20100256390A1-20101007-C00005
  • wherein Hal, Hal′ and R1 are as defined above, and
  • ii) reacting the compound of formula (IV) with methylhydrazine to give a pyrazole of formula (I).
  • According to a second aspect, the invention provides a process for the preparation of a compound of formula (VI)
  • Figure US20100256390A1-20101007-C00006
  • wherein Hal, Hal′ and R1 are as defined above and R3 is selected from H and C1-6 alkyl comprising reacting a hydrazide of formula (XXIII)
  • Figure US20100256390A1-20101007-C00007
  • wherein Hal, Hal′ and R1 are as defined above,
  • with an alkyl propargylate of formula (XXIV)
  • Figure US20100256390A1-20101007-C00008
  • wherein R3 is as defined above.
  • According to a third aspect, the invention provides a process for the preparation of a compound of formula (VI)
  • Figure US20100256390A1-20101007-C00009
  • wherein Hal, Hal′ and R1 are as defined above and R3 is selected from H and C1-6 alkyl comprising reacting a compound of formula (XXV)
  • Figure US20100256390A1-20101007-C00010
  • wherein Hal, Hal′, R1 and R3 are as defined above with chloramine.
  • According to a fourth aspect, the invention relates to a compound of formula X
  • Figure US20100256390A1-20101007-C00011
  • According to a fifth aspect, the invention relates to a compound of formula VIII
  • Figure US20100256390A1-20101007-C00012
  • According to a sixth aspect, the invention relates to a compound of formula VII
  • Figure US20100256390A1-20101007-C00013
  • DETAILED DESCRIPTION OF THE INVENTION
  • In step i) of the reaction according to a first embodiment of the invention, a compound of formula (II) reacts with an enol ether of formula (III) to give a 4-alkoxy-3-en-2-one of formula (IV) (Scheme 1)
  • Figure US20100256390A1-20101007-C00014
  • As used herein, the term “leaving group” refers to a moiety that can be displaced by enol ether (III) to form a carbon-carbon bond present in compound (IV). Preferred leaving groups are halogens. A more preferred leaving group is chlorine.
  • Preferably, R2 is ethyl.
  • The reaction of compound (II) with the enol ether (III) may take place in a suitable solvent. Alternatively, and preferably, the reaction takes place in the absence of a solvent.
  • Preferred solvents are toluene, hexane, dichloromethane and diethylether.
  • Preferably, the reaction is conducted under an inert atmosphere. More preferably, the reaction is conducted under a nitrogen atmosphere. Preferably, the reaction proceeds with purge to help remove volatile co-products.
  • In one embodiment, the reaction takes place in the presence of a base. Preferred bases are pyridine, alkyl pyridines or trialkylamines. Preferably, however, the reaction occurs in the absence of base.
  • Preferably, the enol ether (III) is present in excess relative to the compound (II). More preferably, the enol ether is present in an amount of between 1.1 and 10 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of between 1.2 and 5 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of between 1.5 and 2.5 equivalents relative to the amount of compound (II) on a molar basis. More preferably, the enol ether is present in an amount of about 2 equivalents relative to the amount of compound (II) on a molar basis.
  • Preferably, the enol ether (III) is added to the compound (II). More preferably, the enol ether (III) is added to the compound (II) over at least 1 hour. More preferably, the enol ether (III) is added to the compound (II) over at least 4 hours. More preferably, the enol ether (III) is added to the compound (II) over about 8 hours.
  • Preferably, the reaction is cooled during the addition of the enol ether (III) to the compound (II). Preferably, the reaction is cooled to between −20 and −40° C. during the addition of the enol ether (III) to the compound (II).
  • Subsequent to the addition of the enol ether (III) to the compound (II), the reaction is allowed to continue. The skilled person will be aware that it may be advantageous to monitor the course of the reaction. Suitable techniques are set out in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999, and include for example thin layer chromatography, gas chromatography, and high performance liquid chromatography (HPLC).
  • Preferably, the reaction is allowed to continue for at least 1 hour. More preferably, the reaction is allowed to continue for at least 6 hours. More preferably, the reaction is allowed to continue for at least 8 hours.
  • The skilled person will be aware that work up of the reaction mixture may be necessary or desirable to isolate the 4-alkoxy-3-en-2-one of formula (IV), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • The skilled person will also be aware of purification techniques suitable for purifying the 4-alkoxy-3-en-2-one of formula (IV). Suitable techniques include recrystallization, distillation, and chromatography.
  • In some embodiments of the invention, however, purification of (IV) is unnecessary, and the crude (IV) may be used directly in the next step.
  • In step ii) of the reaction according to a first embodiment of the invention, a 4-alkoxy-3-en-2-one of formula (IV) reacts with methyl hydrazine to give a 3-halomethyl-1-methyl-1H-pyrazole (I) (Scheme 2).
  • Figure US20100256390A1-20101007-C00015
  • The reaction of compound (IV) with methyl hydrazine preferably takes place in a suitable solvent. Alternatively the reaction takes place in the absence of a solvent.
  • Preferred solvents are xylene, toluene, mesitylene, tert-butyl benzene, chlorobenzene, 1,2-dichlorobenzene, tetrahydrofuran, diethyl ether and hexane. A more preferred solvent is tetrahydrofuran.
  • Preferably, methyl hydrazine is used in an amount of 0.7 to 1.3 equivalents relative to the amount of 4-alkoxy-3-en-2-one of formula (IV).
  • Preferably, the methyl hydrazine is added to the 4-alkoxy-3-en-2-one of formula (IV). Preferably, both the methyl hydrazine and the 4-alkoxy-3-en-2-one of formula (IV) are both dissolved in solvent. Addition preferably takes place over a period of between 5 minutes and 10 hours, more preferably over about 5 hours.
  • The reaction is preferably held at between 0 to 50° C., more preferably at between 35 to 45° C.
  • The skilled person will be aware that it may be advantageous to monitor the course of the reaction. Suitable techniques are set out in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999, and include for example thin layer chromatography, gas chromatography, and high performance liquid chromatography (HPLC).
  • The skilled person will be aware that work up of the reaction mixture may be necessary or desirable to isolate the pyrazole (I), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • The skilled person will also be aware of purification techniques suitable for purifying the pyrazole (I). Suitable techniques include recrystallization, distillation, and chromatography.
  • In some embodiments of the invention, however, purification of (I) is unnecessary, and the crude (I) may be used directly in the next step.
  • Halogenation
  • According to one embodiment, pyrazole (I) is subjected to a halogenation step to convert it to 4-halopyrazole of formula (V) (Scheme 3)
  • Figure US20100256390A1-20101007-C00016
  • wherein X is a halogen.
  • Many suitable reaction conditions exist for the halogenation of aromatic compounds. Suitable methods are disclosed for example in Advanced Organic Chemistry, J. March, John Wiley and Sons, 1992, pages 531 to 534.
  • Preferably, the halogenation reaction is conducted in a solvent. A preferred solvent is carbon tetrachloride.
  • Preferably, the reaction is conducted under an inert atmosphere. More preferably, the reaction is conducted under a nitrogen atmosphere. Preferably, the reaction proceeds with purge to help remove volatile co-products.
  • Preferably, X is Br. In this embodiment, a preferred halogenating agents are elemental bromine (Br2), N-bromosuccinimide and 1,3-dibromo-5,5-dimethylhydantoin. More preferably, the halogenating agent is Br2 in the presence of an iron compound, preferably iron powder.
  • Preferably, the halogentating agent is used in excess relative to pyrazole (I). More preferably, the halogentating agent is used in amount of 1.5 to 5 equivalents relative to pyrazole (I) on a molar basis.
  • Preferably, the reaction is allowed to continue for at least 1 hour. More preferably, the reaction is allowed to continue for from 1 to 48 hours. More preferably, the reaction is allowed to continue for from 1 to 5 hours.
  • The skilled person will be aware that it may be advantageous to monitor the course of the reaction. Suitable techniques are set out in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999, and include for example thin layer chromatography, gas chromatography, and high performance liquid chromatography (HPLC).
  • The skilled person will be aware that work up of the reaction mixture may be necessary or desirable to isolate the 4-halopyrazole (V), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • The skilled person will also be aware of purification techniques suitable for purifying the 4-halopyrazole (V). Suitable techniques include recrystallization, distillation, and chromatography.
  • In some embodiments of the invention, however, purification of (V) is unnecessary, and the crude (V) may be used directly in the next step.
  • Carbonylation
  • According to one embodiment, 4-halopyrazole (V) is subjected to a carbonylation step to convert it to 4-carboxypyrazole of formula (VI) (Scheme 4)
  • Figure US20100256390A1-20101007-C00017
  • wherein R3 is H or C1-6 alkyl.
  • Preferably, R3 is Ethyl or H. Reagent R3OH is preferably present in excess relative to 4-halopyrazole (V), preferably in an amount of from 100 to 150 equivalents relative to the amount of (V) on a molar basis.
  • Carbon monoxide is preferably used in excess relative to the amount of (V).
  • Preferably, the reaction takes place in the presence of a palladium catalyst. The palladium catalyst is preferably a palladium (II) or palladium (0) catalyst. Preferred catalysts are tris(triphenylphosphine) palladium (II) chloride, bis(triphenylphosphine) palladium (II) chloride, and tetrakis(triphenylphosphine)palladium(0). A preferred catalyst is tris(triphenylphosphine) palladium (II) chloride. Preferably, the palladium catalyst is used in an amount of between 0.01 and 0.5 equivalents relative to the amount of 4-halopyrazole (V), more preferably between 0.1 and 0.3 equivalents.
  • Preferably, additional triphenylphosphine is added to the reaction, preferably in an amount of 0.5 to 0.7 equivalents.
  • Preferably, the reaction is conducted at a temperature of from 50 to 200° C., more preferably at a temperature of from 100 to 150° C.
  • The reaction is preferably carried out in the presence of a base. Preferred bases are nitrogen-containing organic bases, preferably tertiary amines, more preferably trialkylamines, preferably trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine. Alternative preferred bases are N,N-dimethylaniline or N-methylmorpholine, piperidine, pyrrolidine, alkali metal or alkaline earth metal alcoholates, preferably lithium, sodium or potassium alcoholates, preferably methanolates, ethanolates or butanolates, or inorganic bases, preferably hydroxides, more preferably NaOH or KOH, or hydrides, preferably NaH.
  • Very preferred bases to which preference is given are tertiary amines, preferably trialkylamines, more preferably trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine. Triethylamine is very highly preferred.
  • Suitable amounts of base for that reaction are, for example, from 1 to 10 equivalents, especially from 4 to 6 equivalents.
  • The reaction time is generally from 1 to 48 hours, preferably from 1 to 36 hours, more preferably 1 to 18 hours.
  • The reaction according to the invention is carried out typically at elevated pressure, preferably 1 to 20 bar, more preferably 10 to 15 bar.
  • The skilled person will be aware that it may be advantageous to monitor the course of the reaction. Suitable techniques are set out in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999, and include for example thin layer chromatography, gas chromatography, and high performance liquid chromatography (HPLC).
  • The skilled person will be aware that work up of the reaction mixture may be necessary or desirable to isolate the 4-carboxypyrazole (VI), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • The skilled person will also be aware of purification techniques suitable for purifying the 4-carboxypyrazole (VI). Suitable techniques include recrystallization, distillation, and chromatography.
  • In some embodiments of the invention, however, purification of (VI) is unnecessary, and the crude (VI) may be used directly in the next step.
  • Hydrolysis
  • In embodiments of the invention wherein R3 is other than hydrogen in 4-carboxypyrazole (VI), an optional further step comprises hydrolyzing the group R3 to a compound (VI) wherein R3 is hydrogen, or a salt form thereof (Scheme 5).
  • Figure US20100256390A1-20101007-C00018
  • wherein R3 is C1-6 alkyl
  • The skilled person will be aware of many suitable methods for the hydrolysis of esters to carboxylic acids. Some exemplary conditions are detailed in Advanced Organic Chemistry, J. March, John Wiley and Sons, 1992, pages 378 to 383.
  • Hydrolysis can be effected under either acid or basic conditions. If basic conditions are employed, generally a salt form of 4-carboxypyrazole (VI) is obtained. A further step of acidification to convert the salt to the free acid may be employed.
  • Preferred bases for the hydrolysis reaction are metal hydroxides and metal carbonates. More preferred bases are alkali metal hydroxides. Still more preferred are sodium, potassium and lithium hydroxide. Most preferred is sodium hydroxide.
  • Preferably, the base is used in excess relative to 4-carboxypyrazole (VI). More preferably, between 1 and 5 equivalents of base are used. Still more preferably, between 1 and 3 equivalents of base are used.
  • Suitably, water is present in excess. Preferably, a co-solvent is present. A preferred co-solvent is ethanol.
  • The hydrolysis preferably takes place at between 0 and 200° C., more preferably at between 50 and 150° C.
  • After the hydrolysis reaction is complete, the free acid (VI) may be liberated by treatment with acid. Preferred acids are mineral acids, preferably hydrochloric or sulphuric acid. Most preferred is hydrochloric acid.
  • If hydrolysis is effected under acid conditions, mineral acids or organic acids may be used. Preferred are mineral acids. More preferred are hydrochloric and sulphuric acid. Most preferred is hydrochloric acid.
  • Preferably, at least 0.01 equivalents of acid relative to the amount of (VI) on a molar basis are employed, more preferably between 0.01 and 5 equivalents, still more preferably 1 to 5 equivalents.
  • Preferably, acid hydrolysis occurs at a temperature of between 40 and 100° C.
  • The skilled person will be aware that it may be advantageous to monitor the course of the reaction. Suitable techniques are set out in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999, and include for example thin layer chromatography, gas chromatography, and high performance liquid chromatography (HPLC).
  • The skilled person will be aware that work up of the reaction mixture may be necessary or desirable to isolate the 4-carboxypyrazole (VI), if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • The skilled person will also be aware of purification techniques suitable for purifying the 4-carboxypyrazole (VI). Suitable techniques include recrystallization, distillation, and chromatography.
  • Halogen Exchange.
  • In one embodiment of the invention, the reaction sequence includes a halogen exchange step.
  • The term “halogen exchange”, as used herein, refers to a reaction wherein halogen atoms of one element are exchanged for halogen atoms of a second, different element. Preferably, chlorine atoms are exchanged for fluorine atoms.
  • Halogen exchange may be conducted at any suitable step of the reaction sequence.
  • In a preferred embodiment, halogen exchange is effected on 3-dichloromethyl-1-methyl-1H-pyrazole (VII) to give 3-difluoromethyl-1-methyl-1H-pyrazole-4-carbaldehyde (VIII) (Scheme 6).
  • Figure US20100256390A1-20101007-C00019
  • In an alternative embodiment, halogen exchange is effected on 4-bromo-3-dichloromethyl-1-methyl-1H-pyrazole (IX) to give 4-bromo-3-fluoromethyl-1-methyl-1H -pyrazole (X) (Scheme 7).
  • Figure US20100256390A1-20101007-C00020
  • In an alternative embodiment, halogen exchange is effected on 3-dichloromethyl-1-methyl-1H-pyrazole-4-carboxylate (XI) or a salt form thereof to give 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylate (XII) (Scheme 8).
  • Figure US20100256390A1-20101007-C00021
  • Halogen exchange may be conducted under a variety of conditions. Preferably, halogen exchange is conducted in the presence of a source of F ions. Preferred reagents are AgF, KF, HgF2, Bu4N+ HF2−, BrF3, Et3N.2HF, Et3N.3HF and HF plus SbF3. A very highly preferred reagent is Et3N.3HF.
  • The halogen exchange reaction is optionally conducted in a solvent. Alternatively, and preferably, the reaction is conducted under solvent-free conditions.
  • Preferably, the reaction is held at between 0 and 250° C. More preferably, the reaction is held at between 50 and 200° C. More preferably, the reaction is held at between 125 and 175° C. Most preferably, the reaction is held at about 150° C.
  • Again, the skilled person will be aware of techniques for monitoring the course of the halogen exchange reaction in order to judge when it is complete. HPLC is particularly useful in this context.
  • The skilled person will be aware that work up of the reaction mixture may be necessary or desirable to isolate the product of the halogen exchange reaction, if isolation is intended. Suitable work up procedures are described for example in Experimental Organic Chemistry standard and microscale (2nd Edition), L. M. Harwood, C. J. Moody, and J. M. Percy, Blackwell Scientific, 1999.
  • The skilled person will also be aware of purification techniques suitable for purifying the reaction product. Suitable techniques include recrystallization, distillation, and chromatography.
  • Second Embodiment
  • In the second embodiment of the invention, hydrazide (XXIII) reacts with propargylate (XXIV) to give 4-carboxypyrazole (VI) (Scheme 9)
  • Figure US20100256390A1-20101007-C00022
  • Preferably, the reaction takes place in a solvent. Dimethylformamide is preferred.
  • Preferably, the reaction occurs under acid catalysis. p-Toluene sulphonic acid is preferred.
  • 4-carboxypyrazole (VI) may be hydrolysed to the free acid or a salt form thereof as outlined above.
  • Third Embodiment
  • In the third embodiment of the invention, enamine (XXV) reacts with chloramine to give 4-carboxypyrazole (VI) (Scheme 10)
  • Figure US20100256390A1-20101007-C00023
  • Preferably, the enamine (XXV) is reacted with a base prior to reaction with chloramine. A preferred base is sodium hydride.
  • Preferably, the reaction takes place in a solvent. Preferred solvents are diethyl ether, tetrahydrofuran and mixtures thereof.
  • 4-carboxypyrazole (VI) may be hydrolysed to the free acid or a salt form thereof as outlined above.
  • Preferred Embodiments
  • In a preferred embodiment, Hal, Hal′ and R1 are all fluorine.
  • In another preferred embodiment, Hal and Hal′ are fluorine and R1 is hydrogen.
  • In another preferred embodiment, Hal and Hal′ are both chlorine, and R1 is hydrogen.
  • In a preferred embodiment, the present invention relates to a process for the production of a compound of formula XIII
  • Figure US20100256390A1-20101007-C00024
  • which comprises
  • b1) reacting a compound of formula XIV (dichloroacetyl chloride)
  • Figure US20100256390A1-20101007-C00025
  • with a compound of formula III
  • Figure US20100256390A1-20101007-C00026
  • wherein R1 is C1-C6alkyl, to form a compound of formula XV
  • Figure US20100256390A1-20101007-C00027
  • wherein R1 is as defined above;
  • b2) converting that compound with methylhydrazine into a compound of formula VII (3-dichloromethyl-1-methyl-1H-pyrazole)
  • Figure US20100256390A1-20101007-C00028
  • b3) fluorinating that compound with a fluorinating agent into a compound of formula VIII (3-difluoromethyl-1-methyl-1H-pyrazole)
  • Figure US20100256390A1-20101007-C00029
  • b4) brominating that compound with a brominating agent into a compound of formula X (4-bromo-3-difluoromethyl-1-methyl-1H-pyrazole)
  • Figure US20100256390A1-20101007-C00030
  • b5) converting that compound with carbon monoxide and a C1-C6alkanol in the presence of a palladium catalyst into a compound of formula XII
  • Figure US20100256390A1-20101007-C00031
  • wherein R2 is C1-C6alkyl; and
  • b6) saponifying that compound leading to the formation of the compound of formula (XIII) by
  • b6.1) adding a hydroxide base or water in the presence of a base to form the anion of the compound of formula (XIII) and then adding an acid to form the compound of formula (XIII); or
  • b6.2) adding water in the presence of an acid to form the compound of formula (XIII).
  • Process Step b1):
  • In process step b1) single compounds of formula (III), such as compounds of formula (III), wherein R1 is ethyl, can be used or mixtures thereof. An example of such a mixture are compounds of formula (III), wherein in R1 is methyl, mixed with compounds of formula (III), wherein R1 is ethyl. In preferred compounds of formula (III), R1 is ethyl.
  • The reaction according to the invention is preferably carried out in a temperature range of from −40° C. to 0° C., especially from −40° C. to −20° C.
  • The reaction can be carried out in the presence or absence of a base. Preferred bases include pyridine, alkyl pyridines or trialkylamines.
  • The reaction can be carried out without solvent or in an inert solvent. Preferred inert solvents are, for example, toluene, hexane, dichloromethane or diethylether. Preferably, the reaction is carried out without a solvent.
  • In the reaction according to the invention, the compound of formula (III), for example ethylenol ether, can be used in equimolar amounts, in sub-equimolar amounts or in excess relative to compounds of formula XIV, preferably the compound of formula (III) is used in excess, more preferably in an 1.5-fold to 3-fold excess.
  • The reaction according to the invention may be carried out in a dry inert gas atmosphere. For example, nitrogen can be used as inert gas.
  • The reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours.
  • The reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
  • Process Step b2):
  • The reaction according to the invention is preferably carried out in a temperature range of from 0° C. to 50° C., especially from 10° C. to 25° C.
  • The reaction is conveniently carried out in an inert solvent. Preferred inert solvents are, for example, xylene, toluene, mesitylene, tert-butyl benzene, chlorobenzene, 1,2-dichlorobenzene, tetrahydrofuran, diethyl ether and hexane, preferably tetrahydrofuran.
  • In the reaction according to the invention, methylhydrazine can be used in equimolar amounts, in sub-equimolar amounts or in excess relative to compounds of formula XV, preferably methylhydrazine is used in equimolar amounts.
  • The reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
  • The reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
  • Process Step b3):
  • The fluorination according to the invention is preferably carried out in a temperature range of from 100° C. to 200° C., especially from 140° C. to 160° C.
  • The preferred fluorinating agent is tris(hydrogen fluoride)-triethylamine. The fluorinating agent is typically used in excess relative to compounds of formula VII, preferably in a 2-fold to 5-fold excess.
  • The fluorination can be carried out without solvent or in an inert solvent. Preferred inert solvents are, for example, acetonitrile, chloroform, carbon tetrachloride and dichloromethane. Use of excess tris(hydrogen fluoride)-triethylamine, which then acts as solvent is preferred.
  • The reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
  • The reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at elevated pressure.
  • Process Step b4):
  • The bromination according to the invention is preferably carried out in a temperature range of from 0° C. to 100° C., preferably from 20° C. to 40° C.
  • The reaction is conveniently carried out in an inert solvent. A preferred inert solvent is, for example, carbon tetrachloride.
  • Preferred brominating agents are, for example, bromine in the presence of an iron catalyst, N-bromosuccinimide and 1,3-dibromo-5,5-dimethylhydantoin; preferably bromine in the presence of an iron catalyst.
  • In case the brominating agent is bromine in the presence of an iron catalyst, said bromine is typically used in excess relative to compounds of formula VIII, preferably in a 1.5-fold to 5-fold excess; and said iron catalyst is used typically in the form of iron powder and in the range of from 0.1 to 1 equivalents relative to compounds of formula VIII, especially from 0.3 to 0.8 equivalents.
  • The reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours, more preferably 1 to 5 hours.
  • The reaction according to the invention can be carried out at normal, elevated or reduced pressure. In one embodiment of the invention the reaction is carried out at normal pressure.
  • Process Step b5):
  • For process step b5) the preferred C1-C6alkanol is ethanol; but also mixtures C1-C6alkanols can be used, such as a mixture of methanol/ethanol.
  • The reaction according to the invention is preferably carried out in a temperature range of from 50° C. to 200° C., especially from 100° C. to 150° C.
  • The reaction is conveniently carried out in a large excess of the C1-C6alkanol, such as a 100-fold to 150-fold excess, which then acts as solvent. Typically ethanol is used. Typically also a large excess of carbon monoxide is used.
  • A suitable palladium catalyst is tris(triphenylphosphonium)palladium(II)chloride. Said palladium catalyst is used generally in the range of from 0.1 to 0.5 equivalents relative to compounds of formula X, especially from 0.1 to 0.3 equivalents. If tris(triphenylphosphonium)palladium(II)chloride is used as palladium catalyst, then generally triphenyl phosphine is also added to the reaction mixture in amounts of from 0.5 to 0.7 equivalents relative to compounds of formula X.
  • The reaction is carried out preferably in the presence of a base. Suitable bases are, for example, nitrogen-containing organic bases, such as, for example, tertiary amines, such as trialkylamines, e.g. trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine, N,N-dimethylaniline or N-methylmorpholine, piperidine, pyrrolidine, alkali metal or alkaline earth metal alcoholates, such as, for example, lithium, sodium or potassium alcoholates, especially methanolates, ethanolates or butanolates, or inorganic bases, such as hydroxides, e.g. NaOH or KOH, or hydrides, such as, for example, NaH. Bases to which preference is given are tertiary amines, such as trialkylamines, e.g. trimethylamine, triethylamine, diisopropylethylamine (Hünig's Base), or tri-n-butylamine, especially triethylamine. Suitable amounts of base for that reaction are, for example, from 1 to 10 equivalents, especially from 4 to 6 equivalents.
  • The reaction time is generally from 1 to 48 hours, preferably from 1 to 36 hours, more preferably 1 to 18 hours.
  • The reaction according to the invention is carried out typically at elevated pressure, such as 1 to 20 bar, preferably 10 to 15 bar.
  • Process Step b6):
  • Process step b6), the saponification of compounds of formula (XII) to form the compound of formula (XIII), can be carried out as described under step b6.1) (alkaline saponification) or under step b6.2) (acidic saponification).
  • Process Step b6.1):
  • Step b6.1) can be divided into two sub-steps: i) the formation of the anion of the compound of formula (XIII) (“the anion”) by adding a base and ii) the formation of the compound of formula (I) (“the free acid”) by later adding an acid.
  • If a hydroxide base is used to form the anion, then NaOH or KOH, especially NaOH, is preferred. A suitable amount of hydroxide base is, for example, at least one equivalent relative to compounds of formula (XII), preferably from 1 to 5 equivalents; more preferably from 1 to 3 equivalents.
  • If water in the presence of a base is used to form the anion, then inorganic bases, such as hydroxides, for example LiOH, NaOH or KOH, or carbonates, for example sodium carbonate, are preferred. In one embodiment, at least one equivalent of water and at least one equivalent of the base relative to compounds of formula (XII) are used.
  • The formation of the anion can be carried out in an inert solvent, such as ethanol.
  • The formation of the anion is preferably carried out in a temperature range of from 0° C. to 200° C. The reaction time for anion formation is generally from 1 to 48 hours, preferably from 1 to 18 hours. Said anion formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
  • After formation of the anion, an acid is added to form the compound of formula (XIII).
  • Suitable acids are inorganic acids, such as hydrochloric acid or sulfuric acid; or organic acids, such as formic acid, acetic acid or propionic acid. Preference is given to inorganic acids and special preference is given to hydrochloric acid.
  • In one embodiment of the invention, the acid is added in a temperature range of from 50° C. to 95° C. The reaction time for formation of the free acid is generally from 1 to 48 hours, preferably from 1 to 18 hours. Said free acid formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
  • Process Step b6.2):
  • In process step b6.2) the compound of formula (XIII) (“the free acid”) is formed directly by acidic saponification.
  • The acid used in step b6.2) is typically an inorganic acid, such as hydrochloric acid or sulfuric acid; or an organic acid, such as formic acid, acetic acid or propionic acid.
  • Preference is given to inorganic acids and special preference is given to hydrochloric acid.
  • Typically, aqueous solutions of the acid are used in step b6.2).
  • A preferable amount of water is at least one equivalent relative to compounds of formula (XII).
  • A preferable amount of acid is at least 0.01 equivalents relative to compounds of formula (XII), more preferably from 0.01 to 5 equivalents; even more preferably from 1 to 5 equivalents.
  • The formation of the free acid is preferably carried out in a temperature range of from 40° C. to 100° C. The reaction time is generally from 1 to 48 hours, preferably from 1 to 18 hours. Said free acid formation can be carried out at normal, elevated or reduced pressure, preferably at normal pressure.
  • Also the second embodiment of the present invention makes it possible to produce compounds of formula I in a high yield, with a high degree of regioselectivity and at low cost.
  • The compounds of formula (X), (VII) and (VIII) are valuable intermediates for the preparation of compounds of formula (XIII) and were developed specifically for the present process according to the invention. The present invention accordingly relates also to those compounds.
  • Further aspects of the second embodiment are the following five individual processes:
  • 1) A process for the production of a compound of formula (XII), which comprises b1) reacting a compound of formula (XIV) with a compound of formula (III) to form the compound of formula (XV).
  • 2) A process for the production of a compound of formula (VII), which comprises b2) converting a compound of formula (XV) with methylhydrazine into the compound of formula (VII).
  • 3) A process for the production of a compound of formula (VIII), which comprises b3) fluorinating a compound of formula (VII) with a fluorinating agent into the compound of formula (VIII).
  • 4) A process for the production of a compound of formula (X), which comprises b4) brominating a compound of formula (VIII) with bromine in the presence of an iron catalyst into the compound of formula (X).
  • 5) A process for the production of a compound of formula (XII), which comprises b5) converting a compound of formula (X) with carbon monoxide and a C1-C6alkanole in the presence of a palladium catalyst into the compound of formula (XII).
  • In all five aspects above, the process steps, e.g. steps b1), b2), b3), b4) and b5) are performed as described above.
  • For convenience, the foregoing reactions—and further reactions, descriptions for which will follow—are summarized in scheme 9 below. In scheme 1, R1 and R2 stands for C1-C6alkyl and TREAT HF means tris(hydrogen fluoride)-triethylamine.
  • Figure US20100256390A1-20101007-C00032
    Figure US20100256390A1-20101007-C00033
  • As already discussed above, the invention includes, in separate embodiments, the following multi-step processes, which involve:
  • (1) the formation of (XV) from (XIV);
  • (2) the formation of (VII) from (XV);
  • (3) the formation of (VIII) from (VII);
  • (4) the formation of (X) from (VIII);
  • (5) the formation of (XII) from (X)
  • (6) the formation of (XII) from (XXII)
  • (7) the formation of (XII) from (XX)
  • The following non-limiting examples illustrate the invention in more detail. All following %-values are (w/w)-values unless noted otherwise.
  • EXAMPLES Example 1 Preparation of 1,1-Dichloro-4-ethoxy but-3-en-2-one (XVI)
  • Figure US20100256390A1-20101007-C00034
  • Dichloroacetyl chloride (114.9 g, compound of formula XIV) was charged to a clean/oven dried 250 ml 3-necked flask fitted with nitrogen feed, syringe feed, thermometer and a PTFE coated magnetic stirrer. The reactor was vented via a cold finger condenser and water condenser to follow. A caustic scrubber system was connected to the vent from the water condenser system. The agitation was provided by a magnetic stirrer/hotplate fitted with a drykold acetone bath. The cold finger condenser was filled with the same cooling mixture. The reactor contents were agitated and the contents cooled to <−40° C. with a gentle nitrogen purge applied to the reactor. Ethylenol ether (113.0 g) was charged to the reactor over ˜8 hrs maintaining at −20 to −40° C. throughout. The reaction mixture was then agitated overnight allowing it to self heat to room temperature. The following day the reaction mass was black and more viscous then before. The reaction mass was analyzed by GC/GCMS and shown to have effectively completed. The reactor contents were then agitated under nitrogen whilst samples were removed for Kugelrohr distillation. A total mass of 164.4 g of black liquor was obtained. The yield estimate at this stage for the product (compound of formula IX) was 48% (based on GC area % analysis) with a further potential 15% from the chlorinated intermediate present which had not dehydrochlorinated. Several distillations were carried out obtaining up to 63% recovery of the product with strengths of ˜97% by GC area %. Main fraction was obtained at 137.5° C. and 8 mbar. The product was analysed by GC, GCMS and NMR (1H).
  • GCMS: 35, 43, 48, 53, 61, 71, 76, 83, 91, 99, 109, 119, 182 (M+)
  • 1H NMR (CDCl3): 1.40(t, 3H, CH 3CH2O—), 4.08(q, 2H, CH3CH 2O—), 5.83(s, 1H, CHCl2—), 6.01(d, 1H, —CO—CH═CH), 7.80(d, 1H, —CH═CH—O—)
  • Example 2 Preparation of 3-dichloromethyl-1-methyl-1H-pyrazole (VII)
  • Figure US20100256390A1-20101007-C00035
  • 1,1-Dichloro-4-ethoxy-but-3-en-2-one (0.99 g, compound of formula XVI) was dissolved in tetrahydrofuran (12.5 ml) in a clean/dry 50 ml 3-necked flask fitted with thermometer, condenser and syringe feed system. The top of the condenser was back pressured with a gentle flow of nitrogen. The reactor contents were agitated and heated to 40° C. then the N-methyl hydrazine (0.26 g) was dissolved in tetrahydrofuran (25 ml) and the resultant solution syringe pump fed into the reactor over a 5 hour period. The reaction mixture was agitated overnight under nitrogen to complete. The mixture was allowed to self cool over this period. A yellow/orange solution was obtained. The product solution was concentrated under vacuo and the resultant oil taken up in dichloromethane. The product solution was then washed with water, separated, dried over anhydrous magnesium sulphate and concentrated under vacuo again to give the product in form of a red oil (0.7 g ˜83% yield). The reaction was followed by gas chromatography throughout to assess the extent of reaction. Distillation and separation of the desired product (compound of formula VII) from its isomer is possible—distillation with a Kugelrohr enabled separation of the isomers—the target 1,3-isomer was predominantly obtained at 77° C. and 3 mbar. The unwanted 1,5-isomer was predominantly obtained at 89° C. and 4 mbar. The product was analyzed by GC, GCMS and NMR (1H).
  • GCMS: 35, 43, 48, 53, 61, 71, 76, 83, 91, 99, 109, 119, 182 (M+)
  • 1H NMR (CDCl3): 4.03 (s, 3H, CH 3N), 6.82 (s, 1H, CHCl2), 6.41 (d, 1H, N—CH═CH—), 7.39 (d, 1H, N—CH═CH—)
  • For the isomer:
  • 1H NMR (CDCl3): 3.88 (s, 3H, CH 3N), 6.80 (s, 1H, CHCl2), 6.50 (d, 1H, N—CH═CH—), 7.34 (d, 1H, N—CH═CH—)
  • Example 3 Preparation of 3-difluoromethyl-1-methyl-1H-pyrazole (VIII)
  • Figure US20100256390A1-20101007-C00036
  • 15.4 g (94 mmol) of the compound of formula VII was charged to a clean dry Monel 100 ml pressure reactor followed by 56 g (342 mmol) tris(hydrogen fluoride)-triethylamine by syringe. The system was sealed up and agitated whilst heating the contents to 150° C. After achieving the target temperature the reaction mass was held on temperature for a further 4 hours. External cooling was then applied to cool the reactor/contents to room temperature before the reaction mass was quenched. Quenching was effected by drowning out the reactor contents (black liquid) into water (100 ml). The quenched reaction mass was then extracted with methyl-t-butyl ether (3×25 ml). After separating the organic phases were washed with brine and the organic layer was dried with magnesium sulphate, filtered and concentrated under vacuo to give the compound of formula VIII in the form of a yellow/orange oil (6.3 gm, ˜51% yield on GC area %). The product was analysed by GC, GCMS and NMR (1H, 13C and 19F).
  • GCMS: 38, 42, 51, 81, 113, 117, 132 (M+)
  • For the desired product: 1H NMR (CDCl3): 3.90 (s, 3H, CH 3N), 6.44 (d, 1H, N—CH═CH), 6.68 (t, 1H, CHF2), 7.37 (d, 1H, N—CH═CH); 19F NMR (CDCl2): −111.72 (d, CHF 2)
  • For the isomer: 1H NMR (CDCl2): 3.97 (s, 3H, CH 3N), 6.45 (d, 1H, N—CH═CH), 6.74 (t, 1H, CHF2), 7.44 (d, 1H, N—CH═CH); 19F NMR (CDCl3): −113.11 (d, CHF 2)
  • Example 4 Preparation of 4-Bromo-3-difluoromethyl-1-methyl-1H-pyrazole (X)
  • Figure US20100256390A1-20101007-C00037
  • 1.7 g (30 mmol) iron powder was added to 6.1 g (57 mmol) of the compound of formula VIII in a 250 ml 3-necked round bottom flask fitted with condenser (which was vented to a caustic scrubber system), thermometer and syringe pump feed. The first charge of carbon tetrachloride (25 ml) was made to the flask and the flask contents agitated. Bromine (6.8 g) was dissolved in further carbon tetrachloride (35 ml). Coolant was applied to the condenser, and the bromine solution was fed to the reactor over 1 hr. During the addition the temperature of the reaction rose to −29° C. GC analysis showed that the reaction was incomplete. A second charge of bromine (8.6 g) in carbon tetrachloride (25 ml) was then made to the reactor over a further 1 hr and the reaction mass was allowed to stand overnight. GC analysis showed that the reaction wasn't complete but additional impurities were forming at significant levels. The reaction mass was therefore quenched by treating with sodium bisulphite solution (100 ml)—a small exotherm occurred to 26° C. and the system was decolourised. The two phases were separated and the organic phase was then washed with further sodium bisulphite solution (50 ml). The organic phase was separated from the aqueous phase and dried over magnesium sulphate. The solvent was removed by distillation to give an orange oil (7.5 gm ˜77% yield on actual weight and GC area % strength). The oil was distilled on a kugelrohr short path distillation system at 50 to 96° C. (9 to 6 mbar). The compound of formula X was obtained in the form of a yellow oil over 88 to 96° C. (7 mbar). The main fraction from the distillation was 5.97 g (80% recovery or 62% through yield). Crude and distilled products were analysed by GC, GCMS and NMR (1H and 19F).
  • GCMS: 42, 51, 69, 80, 88, 104, 118, 131, 159, 191, 197, 210 (M+)
  • 1H NMR (CDCl3): 3.91 (s, 3H, CH 3N), 6.67 (t, 1H, CHF2), 7.44 (s, 1H, N—CH═C—Br)
  • 19F NMR (CDCl3): −114.41(d, CHF2)
  • Example 5 Preparation of 3-difluoromethyl-1-methyl-1H-pyrazole-4-caboxylic acid ethyl ester (XVII)
  • Figure US20100256390A1-20101007-C00038
  • 0.43 g 4-Bromo-3-difluoromethyl-1-methyl-1H-pyrazole (X), 10 g ethanol, 1 g triethylamine, 0.11 g tris(triphenylphosphonium)palladium(II)chloride and 0.12 g triphenyl phosphine were charged to a 50 ml glass miniclave reactor fitted with a 10 bar bursting disc, thermometer and gas feed. The system was pre-purged with carbon monoxide six times up to 7 bar—venting off slowly each time and agitating throughout. Finally the reactor was pressurized up to 6 bar. The system was agitated whilst heating up to 150° C. and the pressure maintained at 6-7 bar by venting as necessary. When the mixture had stabilized on temperature, and pressure, it was agitated overnight under these conditions. GC analysis showed the reaction to be incomplete, so a second charge of catalyst (0.06 g tris-triphenylphosphine palladium (II) chloride and 0.14 g triphenylphosphine) was added to the reactor. The reaction was agitated at 150° C. for a further 5 hr then cooled to ambient temperature. The product was not isolated but compared to reference material by HPLC, GC and GCMS. Analysis via GC area % of the reaction mixture suggested a conversion of 60%.
  • Example 6 Preparation of 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (XIII)
  • Figure US20100256390A1-20101007-C00039
  • 0.31 g 4-Bromo-3-difluoromethyl-1-methyl-1H-pyrazole, 0.82 g water, 9 g N-methylpyrrolidinone, 1 g triethylamine, 0.06 g tris(triphenylphosphonium)palladium(II)chloride and 0.12 g triphenyl phosphine were charged to a 50 ml glass miniclave reactor fitted with a 10 bar bursting disc, thermometer and gas feed. The system was pre-purged with carbon monoxide six times up to 7 bar—venting off slowly each time and agitating throughout. Finally the reactor was pressurized up to 6 bar. The system was agitated whilst heating up to 150° C. and the pressure maintained at 6-7 bar by venting as necessary. When the mixture had stabilized on temperature, and pressure, it was agitated overnight under these conditions. The following day the system was cooled, vented and the reactor contents evaporated as far as possible on a rotary evaporator. The resultant oil was quenched with an aqueous base and extracted with 3×25 ml of ether. The combined ether extracts were washed with brine, dried over magnesium sulphate and concentrated under vacuo to yield a red/brown oil (0.5 g). The aqueous base extracts were acidified and back extracted with 3×25 ml of ether. The extracts were combined, dried over magnesium sulphate and concentrated under vacuo. Derivatized GC analysis showed that the desired 1,3-pyrazole isomer (compound of formula XIII) was present in virtually all phases obtained from the work-up (HPLC analysis). Most of the product, and its isomer, were present in the ether extract from the initial base wash. The product was not isolated but compared to reference material by HPLC, derivatized GC and GCMS.
  • Preparation of (XIII) from (XVIII) via (XIX), (XX) and (XVII):
  • Example C4 Preparation of (XX) from (XVIII) via (XIX):
  • Figure US20100256390A1-20101007-C00040
  • Hydrazine hydrate (4.62 g) was charged to a 3-necked round bottomed flask. The flask was fitted with a thermometer, condenser and syringe feed. The system was back pressured on the condenser outlet with a nitrogen purge/bubbler. Methanol (75 ml) was charged to the reactor and the mixture agitated under nitrogen. Methyldifluoroacetate (10.2 g, compound of formula XVIII) was dissolved in methanol (17 ml) and fed, by syringe, into the reactor over 75 minutes. The resultant mixture was transferred to a 300 ml Hastelloy Parr reactor. Formaldehyde (7.4 g) was charged to the reactor and the mixture agitated for 30 minutes at room temperature accompanied by a small exotherm reaction. 1 g Pt/C was added and washed in with methanol (20 ml). The Parr reactor was sealed, purged with nitrogen three times, purged with hydrogen three times (all to 200 psi) and then pressurized up to 200 psi with hydrogen. Agitation and external heating were applied to heat the reaction to 50° C. The reactor was held under these conditions for 3 h and then allowed to cool. The system was purged three times with nitrogen to 200 psi. The contents were removed and filtered. The solvent was removed under vacuum, filtered and concentrated under vacuo. The compound of formula XX was obtained in the form of an orange oil (9.1 g). Yield 40% total isomers and 36% of the desired isomer. The product was analysed by GC, GCMS and NMR (1H and 19F).
  • GCMS: 45, 51, 60, 75, 79, 96, 124 (M+)
  • For the desired product: 1H NMR (CDCl3): 2.67 (s, 3H, CH 3N), 5.95 (t, 1H, CHF2);
  • 19F NMR (CDCl3): −127.92 (d, CHF 2)
  • For the isomer: 1H NMR (CDCl3): 2.59 (s, 3H, CH 3N), 5.92 (t, 1H, CHF2); 19F NMR (CDCl3): −127.94 (d, CHF 2)
  • Example C5 Preparation of (XVII) from (XX)
  • Figure US20100256390A1-20101007-C00041
  • A 25 ml reaction tube was fitted with a magnetic stirrer, thermometer, condenser and nitrogen atmosphere. Dimethylformamide (10 g), ethyl propargylate (0.14 g), the compound of formula XX (0.24 g) and p-toluene sulphonic acid (0.028 g) were charged to the reaction tube. The mixture was stirred at 50° C. overnight, 80° C. overnight and then 110° C. overnight to give the desired product (compound of formula XVII).
  • MS: 42, 43, 112, 132, 140, 159, 176, 204 (M+)
  • 1H NMR (CDCl3): 1.35 (t, 3H, CH 3CH2), 3.97 (s, 3H, NCH 3), 4.32 (q, 2H, CH3CH 2O), 7.25 (t, 1H, CHF2), 7.90 (S, 1H, ArH)
  • The compound of formula (I) can be formed from the compound of formula (V) via step b6) as described above.
  • Preparation of (XIII) from (XVIII) via (XX) and (V):
  • Example C6 Direct Preparation of (XX) from (XVIII)
  • Figure US20100256390A1-20101007-C00042
  • A 3-neck 250 ml round bottomed flask was fitted with a magnetic stirrer, thermometer and nitrogen atmosphere. Tetrahydrofuran (120 ml), methyl difluoroacetate (compound of formula XVIII; 4 g) and methylhydrazine (1.65 g) were charged, and the mixture stirred at ambient temperature for 4 h. Further methyl hydrazine (0.38 g) was added and the mixture stirred for a further 3 h at ambient temperature. The desired product (compound of formula XX) was formed as a 3:1 mixture with its N-regioisomer and was isolated by concentration in vacuo.
  • MS: 45, 51, 60, 75, 79, 96, 124 (M+)
  • 1H NMR (CDCl3): 2.67 (s, 3H, CH 3N), 5.95 (t, 1H, CHF2)
  • The compound of formula (XVII) can be formed from the compound of formula (XX) via the methology described in comparative example C5 above. The compound of formula (XII) can be formed from the compound of formula (XVII) via step b6) as described above.
  • Preparation of (XIII) from (XXI) via (XXII), (XXIII) and (XVII):
  • Example C7 Preparation of (XXII from (XXI)
  • Figure US20100256390A1-20101007-C00043
  • A 3-neck 50 ml round bottomed flask was fitted with a magnetic stirrer, thermometer, and nitrogen atmosphere. Dichloromethane (36 ml) and the compound of formula XXI (5.0 g) were charged to the reactor and the resulting solution cooled to 0° C. Methylamine (4.20 g) was added over 0.25 h, maintaining the temperature below 5° C., and the reaction stirred at ambient temperature for 1.5 h. Concentration in vacuo gave a yellow solid, which was washed with isohexane (60 ml, 20 ml). The compound of formula XXII was obtained as an off-white solid (86% yield).
  • MS: 42,43, 55, 84, 112, 128, 156, 162, 207 (M+)
  • 1H NMR (CDCl3): 1.32 (t, 3H, CH 3CH2), 3.25 (d, 3H, NHCH 3), 4.23 (q, 2H, CH3CH 2O), 6.88 (t, 1H, CHF2), 8.10 (d, 1H, C═CH), 10.83 (br s, 1H, ═CH—NH—CH3)
  • Example C8 Preparation of (XVII) from (XXII) via XXIII)
  • Figure US20100256390A1-20101007-C00044
  • a) Preparation of Chloramine:
  • A 100 ml conical flask was fitted with a magnetic stirrer and thermometer. Diethyl ether (31 ml) and ammonium chloride (0.91 g) were charged to the flask. The mixture was cooled to −10° C. and aqueous ammonia solution (1.7 g) was added. Sodium hypochlorite (14.3 g) solution was charged over 10 minutes to the vigorously stirred solution at −10° C., and the reaction was then stirred at −10° C. for 0.5 hr. The organic layer was separated, washed with brine, dried over CaCl2 for 1 hr at −15° C. The desired chloramine was generated as a 3% chloramine solution in diethylether.
  • b) Preparation of the Compound of Formula XVII via the Compound of Formula XXIII:
  • A 3-neck round bottomed flask was fitted with a magnetic stirrer, thermometer and nitrogen atmosphere. Sodium hydride in mineral oil (0.28 g, 6.82 mmol, 5.5 eq) was charged to the reactor. The obtained paste was triturated with isohexane (2×10 ml) to remove the mineral oil, then tetrahydrofuran (25 ml) and 0.26 g of the compound of formula XXII (prepared as described in comparative example 7) were added. The mixture was stirred at ambient temperature for 0.5 h to give a clear solution. This tetrahydrofuran solution was added slowly to the chloramine/diethylether-solution described above (6.22 mmol, 5.0 eq) at −15° C. The reaction was stirred at −15° C. for 1 h and then allowed to warm to ambient temperature. A new solution of chloramine in diethylether (2.7% strength) was prepared as described above. Additional sodium hydride dispersion (0.20 g, 4.96mmol, 4.0 eq) and chloramine (new solution) (10.4 g, 5.46 mmol, 4.4 eq) were added and the reaction was stirred for 1 h at ambient temperature. A final charge of sodium hydride dispersion (0.22 g, 5.46 mmol, 4.4 eq) and chloramine (10.7 g, 5.58 mmol, 4.5 eq) was added to the reactor. The reaction was stirred at ambient temperature overnight to give the desired compound of formula XVII.
  • MS: 42, 43, 112, 132, 140, 159, 176, 204 (M+)
  • 1H NMR (CDCl3): 1.35 (t, 3H, CH 3CH2), 3.97 (s, 3H, NCH 3), 4.32 (q, 2H, CH3CH 2O), 7.25 (t, 1H, CHF2), 7.90 (S, 1H, ArH)
  • The compound of formula (XIII) can be formed from the compound of formula (XVII) via step b6) as described above.

Claims (16)

1. A process for the preparation of a compound of formula (I)
Figure US20100256390A1-20101007-C00045
wherein Hal and Hal′ are independently Cl or F, and R1 is H, Cl or F,
comprising the steps of
i) reacting a compound of formula (II)
Figure US20100256390A1-20101007-C00046
wherein Hal, Hal′ and R1 are as defined above, and LG is a leaving group, with an enol ether of formula (III)
Figure US20100256390A1-20101007-C00047
to give a compound of formula (IV)
Figure US20100256390A1-20101007-C00048
wherein Hal, Hal′ and R1 are as defined above, and
ii) reacting the compound of formula (IV) with methylhydrazine to give a pyrazole of formula (I).
2. A process according to claim 1, comprising a further step of halogenating the compound of formula (I) to give a 4-halopyrazole of formula (V)
Figure US20100256390A1-20101007-C00049
wherein Hal, Hal′ and R1 are as defined in claim 1 and X is Cl, Br or I.
3. A process according to claim 2, comprising the further step of reacting the compound of formula (V) with carbon monoxide in the presence of water or a C1-6 alcohol to give a compound of formula (VI)
Figure US20100256390A1-20101007-C00050
wherein Hal, Hal′ and R1 are as defined in claim 1 and R3 is selected from H and C1-6 alkyl.
4. The process according to claim 3 1 wherein the reaction is conducted in the presence of a palladium catalyst.
5. A process according to claim 3, comprising the further step of hydrolyzing a compound of formula (VI) wherein R3 is C1-6 alkyl to a compound of formula (VI) wherein R3 is H or a salt form thereof.
6. A process according to claim 1, wherein Hal and Hal′ are F, and R1 is H.
7. A process according to claim 1 wherein Hal and Hal′ are Cl, and R1 is H.
8. A process according to claim 7, comprising a step of halogen exchange to convert Hal and Hal′ from Cl to F.
9. A process according to claim 1 wherein Hal, Hal′ and R1 are F.
10. A process for the preparation of a compound of formula (VI)
Figure US20100256390A1-20101007-C00051
wherein Hal, Hal′ and R1 are as defined in claim 1 and R3 is selected from H and C1-6 alkyl comprising reacting a hydrazide of formula (XXIII)
Figure US20100256390A1-20101007-C00052
wherein Hal, Hal′ and R1 are as defined above,
with an alkyl propargylate of formula (XXIV)
Figure US20100256390A1-20101007-C00053
wherein R3 is as defined above.
11. A process for the preparation of a compound of formula (VI)
Figure US20100256390A1-20101007-C00054
wherein Hal, Hal′ and R1 are as defined in claim 1 and R3 is selected from H and C1-6 alkyl comprising reacting a compound of formula (XXV)
Figure US20100256390A1-20101007-C00055
wherein Hal, Hal′, R1 and R3 are as defined above with chloramine.
12. A process according to claim 10, comprising the further step of hydrolyzing a compound of formula (VI) wherein R3 is C1-6 alkyl to a compound of formula (VI) wherein R3 is H or a salt form thereof.
13. A process according to claim 10, wherein Hal and H′ are F, and R1 is H.
14. A compound of formula X
Figure US20100256390A1-20101007-C00056
15. A compound of formula VIII
Figure US20100256390A1-20101007-C00057
16. A compound of formula VII
Figure US20100256390A1-20101007-C00058
US12/665,738 2007-06-27 2008-06-16 Processes for the preparation of pyrazoles Abandoned US20100256390A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07012546A EP2008996A1 (en) 2007-06-27 2007-06-27 Process for the production of pyrazoles
EP07012546.3 2007-06-27
PCT/EP2008/004830 WO2009000442A2 (en) 2007-06-27 2008-06-16 Processes for the preparation of pyrazoles

Publications (1)

Publication Number Publication Date
US20100256390A1 true US20100256390A1 (en) 2010-10-07

Family

ID=38812166

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/665,738 Abandoned US20100256390A1 (en) 2007-06-27 2008-06-16 Processes for the preparation of pyrazoles
US12/666,179 Active 2028-12-06 US8269020B2 (en) 2007-06-27 2008-06-16 Processes for the preparation of pyrazoles
US13/621,686 Active US8785657B2 (en) 2007-06-27 2012-09-17 Processes for the preparation of pyrazoles

Family Applications After (2)

Application Number Title Priority Date Filing Date
US12/666,179 Active 2028-12-06 US8269020B2 (en) 2007-06-27 2008-06-16 Processes for the preparation of pyrazoles
US13/621,686 Active US8785657B2 (en) 2007-06-27 2012-09-17 Processes for the preparation of pyrazoles

Country Status (18)

Country Link
US (3) US20100256390A1 (en)
EP (3) EP2008996A1 (en)
JP (2) JP2010531315A (en)
KR (2) KR20100025533A (en)
CN (3) CN102516175A (en)
AR (2) AR067356A1 (en)
AU (2) AU2008267473A1 (en)
BR (2) BRPI0813903A2 (en)
CA (2) CA2689218A1 (en)
CL (2) CL2008001897A1 (en)
CO (2) CO6251314A2 (en)
CR (2) CR11161A (en)
EC (2) ECSP099817A (en)
IL (2) IL202419A0 (en)
MX (2) MX2009013591A (en)
RU (2) RU2010102137A (en)
TW (2) TW200916445A (en)
WO (2) WO2009000442A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110009642A1 (en) * 2008-02-25 2011-01-13 Bayer Cropscience Ag Method for the Regioselective Synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic Acid Derivatives
US20130237710A1 (en) * 2008-09-30 2013-09-12 Solvay Sa Process for the synthesis of halogenated cyclic compounds
US10239841B2 (en) 2015-03-26 2019-03-26 AGC Inc. Method for producing pyrazole derivative

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2008996A1 (en) * 2007-06-27 2008-12-31 Syngeta Participations AG Process for the production of pyrazoles
GB0908435D0 (en) * 2009-05-15 2009-06-24 Syngenta Ltd Processes
WO2012025469A1 (en) * 2010-08-24 2012-03-01 Solvay Sa Improved process for the preparation of esters of 1-h-pyrazole-4-carboxylic acids
FR2975992B1 (en) * 2011-06-01 2013-11-08 Rhodia Operations PROCESS FOR THE PREPARATION OF A FLUOROMETHYLPYRAZOLE COMPOUND IN CARBOXYLIC ACID OR DERIVED FORM
FR2975990B1 (en) * 2011-06-01 2013-05-24 Rhodia Operations PROCESS FOR PREPARING A FLUORINE ORGANIC COMPOUND
WO2013171134A1 (en) * 2012-05-14 2013-11-21 Bayer Cropscience Ag Process for preparing 1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carboxylic acid chlorides
US8871947B2 (en) 2013-02-04 2014-10-28 KingChem LLC Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester
ES2689140T3 (en) 2013-10-23 2018-11-08 Bayer Cropscience Aktiengesellschaft Procedure to produce haloketones
CN103570623B (en) * 2013-11-12 2015-05-20 湖南化工研究院 Preparation method of 3-(difluoromethyl)-1-methyl-1H-pyrazol-4-carboxylic acid
WO2015085464A1 (en) 2013-12-09 2015-06-18 King Chem, Llc Process for preparing alkyl 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylate and its analogs
CN103787977B (en) * 2014-01-21 2016-05-25 南通雅本化学有限公司 The method of 3-fluoro-alkyl-1-substituted pyrazolecarboxylic-4-carboxylic acid is prepared in a kind of air oxidation
EP3312161B1 (en) * 2015-06-19 2020-11-04 Zhejiang Yongtai Technology Co., Ltd. Method for preparing pyrazolecarboxylic acid derivative, and intermediate thereof
CN104945325B (en) * 2015-06-19 2017-04-05 浙江永太科技股份有限公司 A kind of preparation method of pyrazole carboxylic acid derivant
WO2017054112A1 (en) 2015-09-28 2017-04-06 常州市卜弋科研化工有限公司 Method of preparing 3-fluoroalkyl-1-methylpyrazole-4-carboxylic acid
CN106554311B (en) * 2015-09-28 2019-03-01 常州市卜弋科研化工有限公司 The preparation method of 3- fluoro-alkyl -1- methylpyrazole -4- carboxylic acid
CN112041303A (en) 2018-05-21 2020-12-04 Pi工业有限公司 Process for preparing substituted heterocyclic compounds
CN109232425A (en) * 2018-10-16 2019-01-18 山东省农药科学研究院 A kind of synthetic method of propenyl benzene fluorine bacterium azoles intermediate 3- (difluoromethyl) -1- methyl-1 H- pyrazoles -4- carboxylic acid
CN110577503A (en) 2019-08-02 2019-12-17 宿迁市科莱博生物化学有限公司 halogen substituted compound and preparation method and application thereof
CN111233768B (en) * 2020-03-18 2021-08-03 徐州圣元化工有限公司 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid ethyl ester
CN111303035A (en) * 2020-03-18 2020-06-19 徐州圣元化工有限公司 Preparation method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic acid
WO2022233129A1 (en) 2021-05-05 2022-11-10 Fujian Yongjing Technology Co., Ltd New process for the synthesis of 5-fluoro-3- (difuoromethyl) -5-fluoro-1-methyl-1h-pyrazole-4-carboxylic acid derivatives and the free acid thereof
CN114195715A (en) * 2021-12-31 2022-03-18 福建永晶科技股份有限公司 Process for preparing 1-methyl-3-difluoromethyl-4-pyrazolic acid and 1-methyl-3-trifluoromethyl-4-pyrazolic acid
CN117384096A (en) * 2023-12-13 2024-01-12 山东国邦药业有限公司 Preparation method of difluoro pyrazole acid
CN117447401B (en) * 2023-12-26 2024-04-19 山东国邦药业有限公司 Synthesis method of difluoro pyrazole acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252944A1 (en) * 2003-10-23 2006-11-09 Reinhard Lantzsch Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759557B2 (en) * 1987-12-25 1995-06-28 三井東圧化学株式会社 Method for producing 1,3-dialkylpyrazole-4-aldehyde derivative
JPH0759558B2 (en) * 1987-12-25 1995-06-28 三井東圧化学株式会社 Process for producing 1,3-dialkylpyrazole-4-aldehydes
JPH089599B2 (en) * 1988-08-02 1996-01-31 三井東圧化学株式会社 Process for producing pyrazole carboxylic acids
AU2003295041A1 (en) * 2002-11-20 2004-06-18 L'oreal Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof
EP1735302B1 (en) * 2004-02-27 2010-06-16 Eli Lilly And Company 4-amino-piperidine derivatives as monoamine uptake inhibitors
WO2005123690A1 (en) * 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-difluoromethyl-pyrazol-4-carbonic acid-(ortho-phenyl)-anilides, and use thereof as a fungicide
PL1781662T3 (en) * 2004-08-18 2011-08-31 Pfizer Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
EP1854788B8 (en) * 2005-02-25 2012-12-26 Sagami Chemical Research Institute Method for producing 1-substituted-3-fluoroalkyl pyrazole-4-carboxylate
TWI436984B (en) * 2005-09-16 2014-05-11 Syngenta Participations Ag Crystal modification of syn-3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid(9-isopropyl-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide and compositions and uses thereof
BRPI0812054B1 (en) * 2007-06-01 2015-12-29 Basf Se process for preparing unsubstituted (3-dihalomethylpyrazol-4-yl) carboxamides
EP2008996A1 (en) * 2007-06-27 2008-12-31 Syngeta Participations AG Process for the production of pyrazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252944A1 (en) * 2003-10-23 2006-11-09 Reinhard Lantzsch Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Braibante et al. Journal of Heterocyclic Chemistry (1993), 30(4), 1159-60 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110009642A1 (en) * 2008-02-25 2011-01-13 Bayer Cropscience Ag Method for the Regioselective Synthesis of 1-Alkyl-3-haloalkyl-pyrazole-4-carboxylic Acid Derivatives
US8629288B2 (en) * 2008-02-25 2014-01-14 Bayer Intellectual Property Gmbh Method for the regioselective synthesis of 1-alky1-3-haloalkyl-pyrazole-4-carboxylic acid derivatives
US20130237710A1 (en) * 2008-09-30 2013-09-12 Solvay Sa Process for the synthesis of halogenated cyclic compounds
US8981115B2 (en) * 2008-09-30 2015-03-17 Solvay Sa Process for the synthesis of halogenated cyclic compounds
US10239841B2 (en) 2015-03-26 2019-03-26 AGC Inc. Method for producing pyrazole derivative

Also Published As

Publication number Publication date
US20130023668A1 (en) 2013-01-24
AU2008267473A1 (en) 2008-12-31
KR20100025533A (en) 2010-03-09
CN101687806A (en) 2010-03-31
RU2010102135A (en) 2011-08-10
KR20100025531A (en) 2010-03-09
US20100240907A1 (en) 2010-09-23
BRPI0813284B1 (en) 2017-10-31
JP2010531314A (en) 2010-09-24
AR067356A1 (en) 2009-10-07
CL2008001897A1 (en) 2009-01-02
WO2009000441A1 (en) 2008-12-31
JP2010531315A (en) 2010-09-24
WO2009000442A3 (en) 2009-07-23
US8269020B2 (en) 2012-09-18
IL202664A0 (en) 2010-06-30
US8785657B2 (en) 2014-07-22
CL2008001896A1 (en) 2009-03-06
JP5563449B2 (en) 2014-07-30
TW200916445A (en) 2009-04-16
WO2009000442A8 (en) 2010-01-21
BRPI0813284A8 (en) 2017-04-04
IL202419A0 (en) 2010-06-30
CN102516175A (en) 2012-06-27
CN101796021A (en) 2010-08-04
EP2167461B1 (en) 2012-08-08
IL202664A (en) 2014-07-31
EP2008996A1 (en) 2008-12-31
CO6251313A2 (en) 2011-02-21
CR11162A (en) 2010-04-21
MX2009013591A (en) 2010-01-20
AU2008267472A1 (en) 2008-12-31
RU2010102137A (en) 2011-08-10
EP2170832A2 (en) 2010-04-07
BRPI0813903A2 (en) 2014-12-30
EP2167461A1 (en) 2010-03-31
TW200914428A (en) 2009-04-01
AR067355A1 (en) 2009-10-07
MX2009013592A (en) 2010-01-20
CO6251314A2 (en) 2011-02-21
WO2009000441A8 (en) 2010-01-14
CA2689218A1 (en) 2008-12-31
ECSP099817A (en) 2010-01-29
ECSP099818A (en) 2010-01-29
BRPI0813284A2 (en) 2014-12-30
WO2009000442A2 (en) 2008-12-31
CR11161A (en) 2010-05-19
CA2690246A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
US20100256390A1 (en) Processes for the preparation of pyrazoles
US7863460B2 (en) Process for producing 1-substituted-3-fluoroalkylpyrazole-4-carboxylate
US20060252944A1 (en) Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl pyrazole-4-carboxylic acid esters
US9096570B2 (en) Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
US8822716B2 (en) Intermediate of cilastatin and preparation method thereof
US7585998B2 (en) Method for producing difluoro-acetyl-acetic acid alkylesters
US7057077B2 (en) Method for producing 2- (alkyl) cycloalkenone
US9145369B2 (en) Process for preparing 1-alkyl-3-fluoroalkyl-1H-pyrazole-4-carboxylic acid chlorides
JP4407896B2 (en) Method for producing 2- (alkyl) cycloalkenone
WO2018180943A1 (en) Method for producing halogen-containing pyrazol carboxylic acid and intermediate thereof
CN107428648B (en) Process for the preparation of compounds such as 3-arylbutyraldehyde useful for the synthesis of medetomidine
NO179100B (en) Process for the preparation of trifluoroacetaldehyde
JP4609610B2 (en) Process for producing 4-methylpyrazole-5-carboxylic acid compound
HU204792B (en) Process for producing 1-aryl-5-aminopyrazole derivatives
JPH06166666A (en) Hydrazone derivative and its production
JP2008297234A (en) Method for producing bromotetrafluoroalkanol
JPH11228485A (en) Production of 3, 3-dimethylbutyric acid
US10273200B2 (en) Practical method for manufacturing 3,3-difluoro-2-hydroxypropionic acid
JPH0361657B2 (en)
JPH06340630A (en) Production of 2-chloro-pyridinemethanol
JPH10265433A (en) Production of phenylpropionic acid derivative
JPS63287741A (en) Beta-fluoroacyl-beta-halovinylalkyl ether
JP4105198B2 (en) Process for producing 1,1-cyclopropanedimethanol
JPH0753456A (en) 1-fluoro-2-oxocycloalkanecarboxylic acid derivative and its salt
JPH072759A (en) Production of tri-substituted benzene and intermediate

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION